Introduction
Patients with Duchenne-like muscular dystrophy showing autosomal recessive inheritance have been reported for several decades ( 1-7 ). Often referred to as severe childhood autosomal recessive muscular dystrophy (SCARMD) ' (8) , it is thought to be genetically heterogeneous (9) (10) (11) , with many different 1 . Abbreviations used in this paper: CK, creatine kinase; RT, reverse transcription; SCARMD, severe childhood autosomal recessive muscular dystrophy.
primary biochemical defects. Deficiency of adhalin (a 50-kD dystrophin-associated glycoprotein) in the skeletal muscle has been found in several families with SCARMD (12) (13) (14) (15) (16) . Recently, complete absence of adhalin in skeletal muscle and missense mutations in the adhalin gene were identified in a single French family with autosomal recessive muscular dystrophy which was less clinically severe than SCARMD (17) . Here we report two consanguineous Japanese families with childhood onset muscular dystrophy where we found complete absence of adhalin in the skeletal muscle. This prompted us to analyze the adhalin gene of these patients for possible mutations.
Methods

Subjects
Three Japanese patients with SCARMD from two unrelated consanguineous families and five unaffected family members were studied. Muscle biopsies were obtained from the three patients and peripheral blood was obtained from them and five family members including their parents.
Methods
Immunohistochemical analysis of biopsied skeletal muscle (12, 16) .
Cryosections (7) (8) prm) of biopsy specimens of skeletal muscle were blocked for 1 h with 5% bovine serum albumin in phosphate-buffered saline (PBS), pH 7.4, and then incubated for 2 h with primary antibodies at the following dilutions: monoclonal antibody VID31 against adhalin, 1:50; monoclonal antibody VIA42 against dystrophin, neat; affinitypurified sheep antiserum against a-dystroglycan, neat: affinity-purified sheep antiserum against 63-dystroglycan, 1:20; affinity-purified sheep antiserum against the 59-kD dystrophin-associated protein, 1:20; affinity-purified sheep antiserum against the 35-kD dystrophin-associated glycoprotein, 1:20. In the case of mouse primary antibodies, cryosections were incubated with 1:200 diluted fluorescence-conjugated antimouse IgG (Boehringer-Mannheim Corp., Indianapolis, IN) for 1 h. In the case of sheep primary antibodies, cryosections were incubated with 1:500 diluted biotinylated anti-sheep IgG (Vector Laboratories, Burlingame, CA) for 1 h, followed by a 30-min incubation with 1:1,000 diluted fluorescence-conjugated streptoavidin (Jackson ImmunoResearch Labs, Inc., West Grove, PA). Each incubation was followed by rigorous washing with PBS.
Analysis of the nucleotide sequence of adhalin cDNA. Total RNA was isolated from 50-mg samples of biopsied skeletal muscle using an RNA Isolation Kite (Stratagene, La Jolla, CA) ( 18 ) . Six sets of primers for reverse transcription-PCR (RT-PCR) (19) were designed to cover the entire cDNA based on the adhalin cDNA sequence reported by Roberds et al. (17) . The primers used were as follows: set a, 5 '-CCA-TGGCTGAGACACTCTTC-3' and 5 '-TGGGTGTAGCGGAGCCAC-3'; set b, 5 '-AGGGACACCCAGACCTGC-3' and 5 '-AGGAACTCG-GCTTGGTATGG-3'; set c, 5 '-GAGGTCACAGCCTACAATCG-3' and 5 '-TCCAAGGCAGAGGTGACGT-3'; set d, 5 '-GGAGAGCFT- 5 '-TCCGCGTTGACTGGTGCAAT-3' and 5 '-ATCTGGATGTCG-GAGGTAGC-3'; set f, 5 '-AGGGAAGGCTGAAGAGAGAC-3' and S '-AGGATGAAGTCAGGGCTGGA-3'. RT 
Results
Clinical data on the patients Family 1; patient 1. This patient is a 23-yr-old female whose parents are first cousins (Fig. 1, Family 1 ). She first walked at 15 mo. She showed an unsteady gait at 3 yr of age with subsequent progressive motor deterioration of the lower extremities. At 8 yr of age, she had difficulty in standing up from a sitting position but she could walk without assistance. At 11 yr, she could walk with support but she could not stand up unaided. She has been confined to a wheelchair since she was 15 yr old.
Her intelligence is normal. She has generalized muscle wasting and muscle weakness, predominantly in the pelvic-girdle region. Immunohistochemical analysis demonstrated the complete absence of adhalin (Fig. 2) , despite nearly normal expression of dystrophin in the sarcolemma (Fig. 2) , and reduced stainings of other dystrophin-associated proteins (data not shown).
Her parents are asymptomatic and a younger sister is healthy. Their serum CK activities are normal. Family 2; patient 1. This patient is a 56-yr-old female whose parents were first cousins (Fig. 1, Family 2) . She started to walk at 18 mo of age, but at 5 yr of age she had difficulty in running and often fell. At 9 yr of age she could not climb up stairs without a handrail, and at 10 yr of age she had a waddling gait. She was unable to walk by herself at 13 yr of age. At 30 yr of age, she was unable to remain in a sitting position. She has been restricted to bed since the age of 35. At 46 yr of age she received a tracheotomy for respiratory failure due to weakness of her respiratory muscles.
Her intelligence is normal. She has marked and generalized muscle wasting, but facial muscles are largely spared. She can barely move her fingers and toes, and deep tendon reflexes of her extremities are absent.
Her serum CK activity is 400 IU/liter (normal level, < 200 rn/liter). A chest x-ray showed no cardiomegaly. An ECG showed a tall R in VI, and QS in leads I and aVL, but an echocardiogram showed no abnormality. A needle EMG of the leg muscles showed a severe myopathic pattern. Histological examination of a biopsy specimen of the anterior tibial muscle showed dystrophic changes, but few opaque fibers. Type I fibers were predominant.
Immunohistochemical examination of skeletal muscle showed complete absence of adhalin (Fig. 2) but the presence of dystrophin (Fig. 2) . Family 2; patient 2. This patient is a 31-yr-old female whose parents are first cousins (Fig. 1, Family 2) . She started to walk at 18 mo of age, but at 5 yr of age she experienced difficulty in running and often fell. From 7 yr old, she had difficulties in climbing stairs unassisted. At 14 yr of age she was unable to walk and was restricted to a wheelchair. Ankylosis of the knee and foot joints was noted.
Her intelligence is normal. Muscle wasting is diffuse and most prominent in the thighs. Her facial muscles are relatively well preserved. Deep tendon reflexes of the extremities are absent.
Her serum CK activity is 680 IU/liter and her serum myoglobin level is 128 ng/ml (normal value, < 60 ng/ml). A chest x-ray showed no apparent cardiomegaly. An ECG showed QS in lead aVL, but an echocardiogram showed no abnormality. An needle EMG gave a typical myopathic pattern. Histological examination of the anterior tibial muscle showed severe dystrophic changes without opaque fibers and no type I fiber predominancy. Immunohistochemical examination showed the absence of adhalin (Fig. 2) Genomic DNA sequences for adhalin Family 1; patient 1. Analysis of the nucleotide sequence of the genomic DNA fragment corresponding to the mutation site in cDNA revealed the same mutation of C to T as in cDNA at nt 229 (data not shown). In this patient, the same nucleotide substitution was identified in all 10 subcloned DNA fragments examined.
Family members in family 1. Genomic DNA of the father of patient 1 showed the same base substitution in three of nine subcloned genomic DNA fragments, while that of her mother showed the same substitution in two of five DNA samples. No mutation at nt 229 was detected in 10 subcloned DNA samples from the patient's younger sister. Family 2; patients I and 2. Substitution of G for A at nt 410 in the genomic DNA fragment was identified. In addition, an insertion of 15 bases was found between nt 408 and nt 409 in both patients. The base sequence of the inserted DNA was 5'-CCTGGTGCGCAGCCA-3' (Fig. 4) . All 10 subcloned DNA fragments of the amplified genomic DNA from patients 1 and 2 had the same mutations.
Family members in family 2. The same nucleotide substitution from A to G at nt 410 and an insertion of 15 bases 5'-CCTGGTGCGCAGCCA-3' were found in three of eight subcloned DNA samples of the father of patient 2 (brother of patient 1), and in three of seven DNA samples of her mother (cousin of patient 2).
Summary of mutations in the families
The changes from C to T in family 1 (patient 1) and from A to G with a 15-base insertion in family 2 (patients 1 and 2) are shown in Fig. 4 .
Neither of these mutations were found by sequencing the subcloned PCR products in 75 normal subjects, and no such nucleotide insertion was detected in the PCR products in 150 normal subjects by abnormal mobility on polyacrylamide gel electrophoresis.
Discussion
We have shown both immunocytochemical deficiency of adhalin in skeletal muscle biopsies and homozygous mutations of the adhalin gene in our two Japanese families with childhood onset muscular dystrophy. Very recently, Roberds et al. (17) found missense mutations in the adhalin gene in a French family with autosomal recessive muscular dystrophy which was clinically less severe than SCARMD. Interestingly, the affected siblings in this family were compound heterozygotes for two different mutant adhalin genes.
Our patients were carrying the diagnosis of malignant limbgirdle muscular dystrophy according to the criteria proposed by Miyoshi et al. (6, 7, 25) which is analogous to the SCARMD disorder. Briefly, symptoms due to muscle weakness developed by 5 yr of age; muscle weakness and wasting were predominant in the proximal muscles and regions of the pelvic girdle; dystrophic changes were detected by histological examination of skeletal muscles; serum CK activity was markedly elevated in young patients and moderately elevated in older patients; the consanguineous parents in both families strongly support an autosomal recessive mode of inheritance.
In the patient of family 1, we found a single base substitution of C for T in the adhalin gene, and in the patients of family 2 we found a single base replacement of A for G associated with an insertion of a 15-base DNA fragment. The presence of the same base sequence near the insertion site suggests duplication of part of the gene in family 2. These gene mutations were homozygous in the patients but heterozygous in their parents, indicating autosomal recessive inheritance. The absence of mutation of the gene in the younger sister of patient 1 is consistent with this mode of inheritance.
The adhalin molecule has a large extracellular domain containing two potential sites for N-linked glycosylation ( 17, 26) . The missense mutations found in our families were located in the region encoding the middle portion of the extracellular domain (17, 26) . The amino acids substituted in our families are conserved between humans and rabbits (17, 26) . The resulting amino acid substitutions are expected to reduce the hydrophilicity of the protein, and furthermore the substitution of Arg by Cys with a sulfhydryl radical (-SH) and the insertion of five amino acids would probably affect the secondary and tertiary structures of adhalin. These could disturb its interaction with other membrane-associated proteins or the components of the basal lamina (16, (26) (27) (28) (29) (30) . It is also conceivable that alteration of the higher order structure of mutant adhalin may cause its rapid degeneration. Interestingly, the missense mutations identified in a French family were also located in the middle portion of the extracellular domain of the adhalin molecule. In this family, which showed a milder phenotype than those of our families, mutations in the adhalin gene caused Arg293His in one allele and Vall75Ala in the other allele (17) . Together, these findings suggest that different sites or types of mutation in the adhalin gene may cause adhalin-deficient muscular dystrophy of various clinical severities. More extensive genotype/ phenotype studies are required on this problem.
Our patients did not suffer from severe cardiac dysfunction or mental retardation. ECGs showed only mild abnormalities compared with those in patients with Duchenne muscular dystrophy (31, 32) with similar grades of muscle dysfunction, and echocardiograms showed no abnormalities in our patients. Indeed, patient 1 in family 1 showed no symptoms of cardiac failure even at 56 yr old. Recently, McNally et al. (33) reported that adhalin mRNA from cardiac muscle is shorter than that from skeletal muscle and lacks the base sequence encoding the transmembrane domain. The less severe cardiac dysfunction in some patients with adhalin-deficient muscular dystrophy may be related to lower expression of the adhalin gene in cardiac muscle and/or the presence of a different isoform of adhalin in cardiac muscle. The absence of mental retardation in these patients is most likely explained by the absence of adhalin expression in the brain (26).
